PXPR007 sgGFP-1 Citations (1)
Originally described in: ATXN1L, CIC, and ETS Transcription Factors Modulate Sensitivity to MAPK Pathway Inhibition.Wang B, Krall EB, Aguirre AJ, Kim M, Widlund HR, Doshi MB, Sicinska E, Sulahian R, Goodale A, Cowley GS, Piccioni F, Doench JG, Root DE, Hahn WC Cell Rep. 2017 Feb 7;18(6):1543-1557. doi: 10.1016/j.celrep.2017.01.031. PubMed Journal
Articles Citing PXPR007 sgGFP-1
| Articles |
|---|
| Characterization and therapeutic suppression of KEAP1-NRF2-driven resistance to KRAS inhibitors in pancreatic and lung cancer. Chang WH, Vaughan AJ, Stamey AG, Mancini M, Hayashi M, Yang R, Robb R, Andrussier D, Klomp JA, Waters AM, Schaefer A, Wolpin BM, Bryant KL, Cox AD, Simabuco FM, Wong KK, Aguirre AJ, Stalnecker CA, Papagiannakopoulos T, Der CJ. bioRxiv [Preprint]. 2026 Apr 21:2026.04.18.719329. doi: 10.64898/2026.04.18.719329. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.